Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Montse Guardiola

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
AIDS Research and Human Retroviruses|June 24, 2015
Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent mannerMontse Guardiola, Patricia Echeverria, Marta González, et al.
Annals of Clinical and Laboratory Science|April 22, 2016
Letter to Editor: Increased Presence of Remnant Lipoprotein Cholesterol in The Hdl of Diabetic SubjectsMarta Gonzàlez, Mercedes Heras, Roser Rosales, et al.
Diabetes Research and Clinical Practice|June 10, 2023
NMR-based metabolomic profiling identifies inflammation and muscle-related metabolites as predictors of incident type 2 diabetes mellitus beyond glucose: The Di@bet.es studyEnrique Ozcariz, Montse Guardiola, Núria Amigó, et al.
Clinical Science (London, England : 1979)|September 11, 2016
APOA5 genetic and epigenetic variability jointly regulate circulating triacylglycerol levelsIris Oliva, Montse Guardiola, Joan-Carles Vallvé, et al.
Clinical Chemistry|August 5, 2006
Protease inhibitor-associated dyslipidemia in HIV-infected patients is strongly influenced by the APOA5-1131T->C gene variationMontse Guardiola, Raimon Ferré, Juliana Salazar, et al.
Atherosclerosis|April 3, 2009
Prox-1 and FOXC2 gene expression in adipose tissue: A potential contributory role of the lymphatic system to familial combined hyperlipidaemiaAlfons Horra, Juliana Salazar, Raimon Ferré, et al.
Cardiovascular Diabetology|November 8, 2024
H-NMR metabolomics identifies three distinct metabolic profiles differentially associated with cardiometabolic risk in patients with obesity in the Di@bet.es cohortEnrique Ozcariz, Montse Guardiola, Núria Amigó, et al.
Journal of the International AIDS Society|November 14, 2014
Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent mannerPatricia Echeverría, Montse Guardiola, Marta González, et al.
International Journal of Rheumatic Diseases|November 20, 2018
Low-density lipoprotein net charge is a risk factor for atherosclerosis in lupus patients independent of lipid concentrationsMarina Rodríguez, Montse Guardiola, Iris Oliva, et al.
Journal of the International AIDS Society|November 14, 2014
Association between lipid genetic and immunological status in chronically HIV-infected patientsPatricia Echeverría, Montse Guardiola, Marta González, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
AIDS Research and Human Retroviruses|June 24, 2015
Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent mannerMontse Guardiola, Patricia Echeverria, Marta González, et al.
Annals of Clinical and Laboratory Science|April 22, 2016
Letter to Editor: Increased Presence of Remnant Lipoprotein Cholesterol in The Hdl of Diabetic SubjectsMarta Gonzàlez, Mercedes Heras, Roser Rosales, et al.
Diabetes Research and Clinical Practice|June 10, 2023
NMR-based metabolomic profiling identifies inflammation and muscle-related metabolites as predictors of incident type 2 diabetes mellitus beyond glucose: The Di@bet.es studyEnrique Ozcariz, Montse Guardiola, Núria Amigó, et al.
Clinical Science (London, England : 1979)|September 11, 2016
APOA5 genetic and epigenetic variability jointly regulate circulating triacylglycerol levelsIris Oliva, Montse Guardiola, Joan-Carles Vallvé, et al.
Clinical Chemistry|August 5, 2006
Protease inhibitor-associated dyslipidemia in HIV-infected patients is strongly influenced by the APOA5-1131T->C gene variationMontse Guardiola, Raimon Ferré, Juliana Salazar, et al.
Atherosclerosis|April 3, 2009
Prox-1 and FOXC2 gene expression in adipose tissue: A potential contributory role of the lymphatic system to familial combined hyperlipidaemiaAlfons Horra, Juliana Salazar, Raimon Ferré, et al.
Cardiovascular Diabetology|November 8, 2024
H-NMR metabolomics identifies three distinct metabolic profiles differentially associated with cardiometabolic risk in patients with obesity in the Di@bet.es cohortEnrique Ozcariz, Montse Guardiola, Núria Amigó, et al.
Journal of the International AIDS Society|November 14, 2014
Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent mannerPatricia Echeverría, Montse Guardiola, Marta González, et al.
International Journal of Rheumatic Diseases|November 20, 2018
Low-density lipoprotein net charge is a risk factor for atherosclerosis in lupus patients independent of lipid concentrationsMarina Rodríguez, Montse Guardiola, Iris Oliva, et al.
Journal of the International AIDS Society|November 14, 2014
Association between lipid genetic and immunological status in chronically HIV-infected patientsPatricia Echeverría, Montse Guardiola, Marta González, et al.
Pageof 5